There is also convincing evidence in the literature that MBL deficiency is associated with increased morbidity risk when immunity is co-compromised by another defect [33], as in cystic fibrosis [34], although the nature of the association may vary [18]. This evidence concerns the gene MBL2 and hyperinsulinemic hypoglycemia, familial, 4.